Home Newsfeeds Guggenheim Upgrades Immunovant to Buy

Guggenheim Upgrades Immunovant to Buy

Guggenheim analyst Yatin Suneja upgrades Immunovant (NASDAQ:IMVT) from Neutral to Buy.

byBenzinga Newsdesk

February 13, 2023

1 minute read

Guggenheim analyst Yatin Suneja upgrades Immunovant (NASDAQ:IMVT) from Neutral to Buy.

Analyst Doubles Immuneering Price Target Citing Initial Data Validation

By Vandana Singh

April 19, 1:50 PM

Tuesday, Immuneering Corporation (NASDAQ:IMRX) announced initial pharmacokinetic (PK), pharmacodynamic (PD), and safety data from the Phase 1 trial of IMM-1-104. IMM-1-104…

IMRX

Paris Hilton, Winklewoss Twins-Backed Startup Aims To Bring Extinct Woolly Mammoth Back To Life

By Shivdeep Dhaliwal

August 17, 3:46 AM

A startup, which counts Winklevoss Capital Management, Paris Hilton and public speaker Tony Robbins among its backers, is planning to bring back to life the long-extinct Tasmanian tiger and the woolly mammoth.

BTC

Sugar Rush Souring: Analyst Downgrades Hershey As 2024 Competition Turns Bitter

By Lekha Gupta

November 21, 3:00 PM

RBC Capital Markets analyst Nik Modi downgraded The Hershey Co (NYSE: HSY) to Sector Perform from Outperform at a

HSY

GameStop Analyst Lowers Price Target After ‘Rambling Presentation By Roaring Kitty’: Does Video Game Company Have ‘Enough Runway To Appease Its Cult-Like Shareholders’?

By Chris Katje

June 12, 1:40 PM

Shares of video game retailer GameStop Corporation (NYSE:GME) have traded higher in recent weeks on optimism from the return of Roaring Kitty (aka Keith Gill) and several share offerings

BTC

Guggenheim Upgrades Immunovant to Buy

Related Posts

Analyst Doubles Immuneering Price Target Citing Initial Data Validation

Paris Hilton, Winklewoss Twins-Backed Startup Aims To Bring Extinct Woolly Mammoth Back To Life

Sugar Rush Souring: Analyst Downgrades Hershey As 2024 Competition Turns Bitter

GameStop Analyst Lowers Price Target After ‘Rambling Presentation By Roaring Kitty’: Does Video Game Company Have ‘Enough Runway To Appease Its Cult-Like Shareholders’?